-transparent.png){kind=logo}
A comparison of preoperative serum tumor markers (lactate dehydrogenase, lactate dehydrogenase isoenzymes, alpha-hydroxybutyrate dehydrogenase, alkaline phosphatase, aldolase, leucine aminopeptidase, cholinesterase, erythrocyte sedimentation reaction, carcinoembryonic antigen, alpha-fetoprotein, and beta 2-microglobulin) was made in 76 patients with ovarian or uterine cancer. Sixty-six patients with benign ovarian tumor served as control subjects. From analysis of each tumor marker the greatest positive results were obtained with the markers beta 2-microglobulin (57.1%), lactate dehydrogenase (53.1%), and hydroxybutyrate dehydrogenase (46.2%) for patients with carcinoma of the ovary. The use of these marker combinations in all ovarian cancer patients resulted in a marked increase of the positive rate from 57.1 to 85.2%. In stage I cases, the positive rate increased from 40.6 to 63.6%.
Y Kikuchi, and
I Kizawa, and
E Koyama, and
K Kato
June 1986,
Minerva ginecologica,
Y Kikuchi, and
I Kizawa, and
E Koyama, and
K Kato
October 1980,
Gynecologic oncology,
Y Kikuchi, and
I Kizawa, and
E Koyama, and
K Kato
February 2009,
Zhonghua fu chan ke za zhi,
Y Kikuchi, and
I Kizawa, and
E Koyama, and
K Kato
April 1998,
World journal of gastroenterology,
Y Kikuchi, and
I Kizawa, and
E Koyama, and
K Kato
November 2014,
Journal of cancer research and therapeutics,
Y Kikuchi, and
I Kizawa, and
E Koyama, and
K Kato
January 2023,
ORL; journal for oto-rhino-laryngology and its related specialties,
Y Kikuchi, and
I Kizawa, and
E Koyama, and
K Kato
December 2015,
Open access Macedonian journal of medical sciences,
Y Kikuchi, and
I Kizawa, and
E Koyama, and
K Kato
October 1989,
Tumori,
Y Kikuchi, and
I Kizawa, and
E Koyama, and
K Kato
January 2006,
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association,
Y Kikuchi, and
I Kizawa, and
E Koyama, and
K Kato
January 1991,
Zhonghua fu chan ke za zhi,
